Physician profile
Neal E Holleran
NPI 1447368766
$2,351.36
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $551 · 2021: $709 · 2022: $403.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $643.33 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $281.76 | 2019-2022 | |
| Abbvie INC. | $236.42 | 2021-2022 | |
| Novo Nordisk INC | $126.72 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $118.40 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.88 | 2019-2022 | |
| Astellas Pharma US INC | $98.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $90.77 | 2019-2022 | |
| Alkermes, INC. | $90.33 | 2020 | |
| Abbott Laboratories | $81.14 | 2021-2022 | |
| Amgen INC. | $80.64 | 2019 | |
| Merck Sharp & Dohme LLC | $74.85 | 2019-2022 | |
| Glaxosmithkline, LLC. | $70.41 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $47.38 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $38.68 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $38.41 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $25.10 | 2021 | |
| Pfizer INC. | $24.10 | 2019 | |
| Eisai INC. | $13.33 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.17 | 2021 | |
| Esperion Therapeutics, INC. | $12.15 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $11.48 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.28 | 2019 | |
| Amarin Pharma, INC. | $11.13 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Holleran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.